0000899243-18-011533.txt : 20180504
0000899243-18-011533.hdr.sgml : 20180504
20180504165226
ACCESSION NUMBER: 0000899243-18-011533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180502
FILED AS OF DATE: 20180504
DATE AS OF CHANGE: 20180504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DOYLE WILLIAM F
CENTRAL INDEX KEY: 0001194459
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 18808639
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Novocure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: LE MASURIER HOUSE, LA RUE LE MASURIER
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4YE
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-02
0
0001645113
Novocure Ltd
NVCR
0001194459
DOYLE WILLIAM F
C/O NOVOCURE INC.,
20 VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
1
1
0
0
Executive Chairman
Ordinary Shares
2018-05-02
4
M
0
293840
A
1055540
D
Ordinary Shares
2018-05-03
4
F
0
28519
27.886
D
1027021
D
Ordinary Shares
43000
I
WFD Ventures Fund II, L.P.
Ordinary Shares
625954
I
WFD-GP II, LLC
Restricted Stock Units
2018-05-02
4
M
0
293840
0.00
D
Ordinary Shares
881519
587679
D
The acquisition of 293,840 ordinary shares resulted from the vesting of an equal number of restricted stock units ("RSUs") on May 2, 2018. The issuer will release one-fifth of the RSUs (58,768
RSUs) as of the date hereof, and will release the other four-fifths on four separate dates hereafter. Mr. Doyle has sold sufficient RSUs to cover the tax liability. After the 293,840 RSUs have been
released, one-half of the remaining RSUs is scheduled to vest on each of May 2, 2019 and May 2, 2020, subject to Mr. Doyle's continued employment through such dates, pursuant to his Restricted
Share Unit Award Notice with NovoCure Limited, dated as of May 2, 2017.
Represents the sale of shares to cover tax withholding obligations in connection with the settlement and release of fully-vested restricted stock units ("RSUs") granted by the issuer to the reporting
person and reported on a Form 4 filed on May 4, 2017.
Mr. Doyle is the Managing Director of WFD Ventures LLC, the sole member of WFD-GP II LLC, which is the general partner of WFD Ventures Fund II, L.P. Mr. Doyle disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest.
RSU represents the right to receive, at settlement, one (1) ordinary share.
/s/ William F. Doyle, Executive Chairman
2018-05-04